2008-11-09 16:56:03 -
- Research and Markets (www.researchandmarkets.com/research/58d29d/cancer_brain_tum) has announced the addition of the "Cancer - Brain Tumor" report to their offering.
Each Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.
In
addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company's full product pipeline and products by phase of development with regard to the therapy area.
Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.
Key Topics Covered:
RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
UPCOMING PATENT EXPIRES BY THERAPY AREA
Brain Tumor Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products Company Overview
- Pipeline Projects
--Company Overview
- Pipeline Projects
--Top Companies in late stage Brain Tumor Projects
--Antisense Pharma GmbH
--Amgen Inc
--AstraZeneca Plc
--Ark Therapeutics Group plc
--DAIICHI SANKYO COMPANY, LIMITED
--BioNumerik Pharmaceuticals, Inc.
--Erimos Pharmaceuticals
--EntreMed Inc
--Genentech Inc
--Ethypharm SA
--MGI Pharma, Inc.
--Keryx Biopharmaceuticals Inc
--Oncovir, Inc
--Nippon Kayaku Co., Ltd.
--Roche Holdings Ltd
--Pharmacyclics Inc
--TransMolecular, Inc.
--Teva Pharmaceutical Industries Ltd
--YM BioSciences Inc
--Vion Pharmaceuticals Inc
--Top Companies in early stage Brain Tumor Projects
--Ariad Pharmaceuticals Inc
--Alfacell Corp
--BioNumerik Pharmaceuticals, Inc.
--AUSTRIANOVA Biotechnology GmbH
--Celgene Corporation
--BioWa, Inc.
--Cylene Pharmaceuticals, Inc.
--Cephalon Inc
--ESBATech AG
--Diffusion Pharmaceuticals LLC
--Lixte Biotechnology Holdings, Inc.
--Kyowa Hakko Kogyo Co., Ltd.
--Merck & Co Inc
--MediGene AG
--NeuroSearch A/S
--NatImmune A/S
--Targepeutics, Inc.
--Reata Pharmaceuticals, Inc.
--TransMolecular, Inc.
--Topotarget A/S
For more information visit
www.researchandmarkets.com/research/58d29d/cancer_brain_tum
Source: Life Science Analytics
Research and Markets
Laura Wood
Senior Manager
press@researchandmarkets.com
Fax from USA: 646-607-1907
Fax from rest of the world: +353-1-481-1716
